ChinaBio生物医药产业合作大会

生物医药产业国际合作大会

2026年4月28-29日|上海浦东嘉里大酒店
2026年5月6-7日|线上
海外ADC专家国内首秀,ChinaBio2026同期下一代疗法会议Antibody&ADC Summit议程公布

海外ADC专家国内首秀,ChinaBio2026同期下一代疗法会议Antibody&ADC Summit议程公布

 

ChinaBioTM Partnering Forum生物医药产业国际合作大会引入海外三十年历史抗体与ADC系列会议,并于大会同期举办Antibody & ADC Summit。

此次活动汇聚了来自美国、欧洲、中国及亚太地区的顶尖抗体科学家,旨在帮助您推进研发进程、优化开发流程,并加速抗体和ADC治疗的商业化进程。

如今正式启航中国!与ChinaBioTM Partnering Forum生物医药产业国际合作大会同期举行意味着不仅能汲取前沿技术知识,更能借助金牌合作平台 partneringONE™与上千位行业决策者高效对接,将创新产品转化为商业合作机遇。

 

多名行业专家中国首秀

*请注意现场演讲语言为英文,不提供任何翻译服务。具体安排以现场为准

Combining Bispecific T-cell Engagers and Costimulatory Agonist Antibodies: An “Off-the-Shelf” Approach for Cancer Therapy

Sara Colombetti, Ph.D., Head of Translational Pharmacology, Roche Oncology pRED, F. Hoffmann-La Roche AG, Switzerland

Folding-mediated Secretion of Pure Bispecific Antibodies

Adam Zwolak, Ph.D., Director, Biologics Discovery, Johnson & Johnson Innovative Medicine, USA

Developing a Pipeline Using FcRn Biology for Degradation of Pathogenic Antibodies

Karen Silence, Ph.D., Head Preclinical Product Development, Argenx, Belgium

Complement Activation Limits the Agonistic Activity of Anti-OX40 Antibodies Engineered for Enhanced Fc-Fc Interaction-mediated Clustering

Bart-Jan de Kreuk, Ph.D., Associate Director, Antibody Format Discovery, Genmab, The Netherlands

 

国际头部ADC玩家加盟

*请注意现场演讲语言为英文,不提供任何翻译服务。具体安排以现场为准

Insights from Two Decades of Clinical and Preclinical Experience with MMAE ADCs

Noah Bindman, Ph.D., Scientific Director of ADC Engineering. Pfizer, USA

New ADC Payload: Antibody Drug Conjugates with a Novel Protein Translation Inhibitor Payload

Tara Arvedson, Ph.D., Chief Scientific Officer, Hexagon Bio, USA

Harnessing the Therapeutic Promise of Multi-payload ADCs

Jerome Boyd-Kirkup, Ph.D., Chief Scientific Officer and Co-Founder, Callio Therapeutics, Singapore

Highly Efficacious and Tolerated Multi-payload ADCs Assembled in One step without Any Antibody Engineering

Filippo Mulinacci, Ph.D., Chief Business Officer, Araris Biotech AG, Switzerland

 

前沿技术现场探讨

*请注意现场演讲语言为英文,不提供任何翻译服务。具体安排以现场为准

How Millions of Affinity Measurements Enable Predictive Multi-Parameter Antibody Optimization in Weeks 

Troy Lionberger, Ph.D., Chief Business Officer, A-Alpha Bio

FAST – Unlocking GPCR-Activating Antibodies with Library-scale Functional Data

Monica Schwartz, Ph.D., Vice President of Antibody Discovery, Abalone Bio, USA

The NovoBody Platform: Computational Design of Next-Generation Single-Chain Antibodies 

Alfredo Quijano Rubio, Ph.D., Co-founder and Chief Scientific Officer, Monod Bio, USA

 

会议信息:

线下:2026年4月28–29日 | 上海浦东嘉里大酒店

线上合作会议:2026年5月6–7日

点击查看议程:2026创新药抗体&ADC合作大会- Antibody & ADC Summit 议程下载 -ChinaBio生物医药产业国际合作大会

微信公众号: CBPF生物医药产业大会

更多会议详细内容与合作机会,请联系大会组委会:

Kathy Ren

电话:21 61573911

邮箱:kathy.ren@informa.com

返回